Searched for
SANOFI STOCK PRICE
Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- Sanofi Consumer Healthcare lists on stock exchanges after demerger, shares hit 5% upper circuit on day 1Shares of Sanofi Consumer Healthcare India made their market debut on Friday, listing on both the NSE and BSE. On its first day of trading,...
- Hold Sanofi India, target price Rs 6270: ICICI DirectSanofi India, incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13505.73 Crore) operating in Pharmaceuticals s...
- Buy Sanofi India, target price Rs 6738: ICICI SecuritiesSanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 12894.50 Crore) operating in Pharmaceutic...
- Buy Sanofi India, target price Rs 8500: Centrum BrokingSanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 14647.01 Crore) operating in Pharmaceutic...
- Buy Sanofi India, target price Rs 9250: Sharekhan by BNP ParibasSanofi reported strong results for Q1CY22 with operating margins expanding 139 bps y-o-y and were better than estimated, leading to a PAT a...
- Sanofi India skids 2% on poor earnings scorecardSanofi India’s counter fell to a low of Rs 7,159 as against the previous close of Rs 7,280.40 on the National Stock Exchange.
- Trending stocks: Sanofi India shares up over 1%A total of 330 shares changed hands on the counter till 10:50AM (IST).
- Sanofi India shares hit 52-week high on Q4 resultsThe stock witnessed similar movement on the NSE as well, where it opened at 7,549.95.
- Analysts slash Sanofi target over Ankleshwar plant saleThe stock ended flat at ₹5,928 on Friday.
- Sanofi India shares tank over 10% on price control orderSanofi India's stock tanked 10.22 per cent to settle at Rs 2,900. In intra-day trade, the scrip plunged 10.99 per cent to Rs 2,875.
- Sanofi India stock likely to be re-rated on company's improving fundamentalsHowever, unlike other multinational pharmaceutical companies, Sanofi India was not analysts’ favourite for quite some time.
- Sanofi extends $18.5 bn bid for Genzyme againIn a statement Sanofi-aventis said its offer of $69 per Genzyme share was extended till February 15 midnight.
- Sanofi extends $18.5bn offer for Genzyme till Jan 21Sanofi-aventis has a significant presence in India. Last year, Sanofi-aventis had sought to acquire an 80pc stake in ShanthaBiotechnics for...
- Sanofi-Aventis likely to buy Genzyme for USD 19 bn: ReportFrench drug maker Sanofi-Aventis is likely to make an formal offer to acquire US-based biotech company Genzyme for USD 19 billion, says a m...
- Sun's EPS may take a knock if it stops cancer drug saleThe stock of Sun Pharma fell for a fourth day in a row, as investors are worried about the company's legal tussle with Sanofi-Aventis over ...
- Piramal Health up 13% on Sanofi stake buyThe news of French drug major Sanofi-Aventis picking up stake in Piramal Healthcare at a premium has resulted in its stock price trading at...
- Sanofi-Aventis revises open offer for Aventis PharmaThe schedule of Sanofi-Aventis' open offer for shareholders of Aventis Pharma Ltd has been revised by DSP Merrill Lynch, manager of the off...
Load More
